# Chemomab Therapeutics Ltd.: Form 8-K, filed Jun 5, 2023

- Company: [Chemomab Therapeutics Ltd.](/companies/cmmb.md) (CIK 1534248)
- Form: 8-K
- Filed: 2023-06-05
- Accepted by EDGAR: Jun 5, 2023, 07:00 ET
- Period: 2023-06-01
- Accession: 0001178913-23-002136
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1534248/000117891323002136/zk2329839.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534248/000117891323002136/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534248/000117891323002136/zk2329839.htm

Filed Jun 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001178913-23-002136. Last ingested by Listed: Nov 2, 2026, 06:08 ET. No prices; not investment advice.